![[Ala28]-β Amyloid(25-35)](https://file.medchemexpress.com/product_pic/hy-p5968.gif "Click to View [Ala28]-β Amyloid(25-35) Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
104 Results for "
amyloid aggregation
" in MedChemExpress (MCE) Product Catalog:
Products (104)
104 Results for "amyloid aggregation" in MCE Product Catalog:
Cat. No.: HY-P3845
CAS No.: 1802086-23-2
Target:
Research Areas:
Cat. No.: HY-P5968
CAS No.: 173993-86-7
Synonyms: β(25-35)KA
Target:
Research Areas:
Cat. No.: HY-P1051A
Synonyms: amyloid β-Protein (12-28) TFA; amyloid Beta-Peptide (12-28) (human) TFA; β-amyloid protein fragment(12-28) TFA
Target:
Research Areas:
Cat. No.: HY-163441
Target:
Research Areas:
BChE-IN-31 (Compound 14d) is a selective BChE inhibitor with an IC50 of 65 nM. BChE-IN-31 inhibits the self-induced aggregation of neurotoxic amyloid-β (Aβ) peptide .
Cat. No.: HY-W004287S
CAS No.: 1219804-90-6
Cat. No.: HY-162832
Target:
Research Areas:
Amyloid-β-IN-1 (compound 13) is a synthetic peptide containing the hydrophobic C-terminal region "VVIA-NH2" and its reverse sequence "AIVV-NH2" of Aβ42, which is an Aβ inhibitor. Amyloid-β-IN-1 can inhibit Aβ aggregation and has neuroprotective effects .
Cat. No.: HY-P10876
Target:
Research Areas:
Cat. No.: HY-13325
CAS No.: 71939-12-3
Target:
Research Areas:
Aβ aggregation modulator-1 is a stimulator of amyloid-β (Aβ) fibrillogenesis. Aβ aggregation modulator-1 binds hydrophobic residues in Aβ peptides and stabilizes β-sheet-rich protofibrils and fibrils. Aβ aggregation modulator-1 accelerates Aβ polymerization and reduces concentrations of small, toxic Aβ oligomers in heterogeneous aggregation reactions. Aβ aggregation modulator-1 suppresses long-term potentiation (LTP) inhibition by Aβ oligomers in hippocampal brain slices. Aβ aggregation modulator-1 can be used for the study of Alzheimer's disease (AD) .
Cat. No.: HY-N9379
CAS No.: 70420-58-5
Category:
Alkaloids Monophenols Annonaceae Extract Goniothalamus amuyon (Bl.) Merr. Other Diseases Phenols Plants Disease Research Fields Isoquinoline Alkaloids
Target:
Cat. No.: HY-W004287R
CAS No.: 1731-88-0
Category:
Cat. No.: HY-176439
CAS No.: 2758789-03-4
Target:
Research Areas:
AChE-IN-88 (Compound 26) is a novel pyridazine derivative. AChE-IN-88 is an orally active multi-target ligand for Alzheimer's disease (AD) that inhibits both acetylcholinesterase (AChE) and amyloid β protein (Aβ) aggregation (pIC50: 7.16) .
Cat. No.: HY-146139
CAS No.: 2477606-87-2
Target:
Research Areas:
Aβ-IN-3 (compound 1) is a potent amyloid β (Aβ) inhibitor. Aβ-IN-3 inhibits Aβ42 aggregation. However, Aβ-IN-3 can not alleviate the neurotoxicity of Aβ42 in SH-SY5Y cells. Aβ-IN-3 can not change the aggregation state of Aβ42 into a nontoxic one .
Cat. No.: HY-146140
CAS No.: 2477606-97-4
Target:
Research Areas:
Aβ-IN-4 (compound 12) is a potent amyloid β (Aβ) inhibitor. Aβ-IN-4 inhibits Aβ42 aggregation. However, Aβ-IN-4 can not alleviate the neurotoxicity of Aβ42 in SH-SY5Y cells. Aβ-IN-4 can not change the aggregation state of Aβ42 into a nontoxic one .
Cat. No.: HY-157296
CAS No.: 3033056-55-9
Target:
Research Areas:
AChE-IN-47 (compound g17) is a AChE inhibitor with the IC50 of 0.24 μM. AChE-IN-47 inhibits amyloid β peptides self-aggregation. AChE-IN-47 displays neuroprotective effects and effectively suppresses the intracellular accumulation of reactive oxygen species .
Cat. No.: HY-163320
CAS No.: 181114-32-9
Target:
Research Areas:
AChE/Aβ-IN-5 (compound AV-2) is a bifunctional inhibitor that targets AChE and auto-induced Aβ (Amyloid-β) aggregation. AChE/Aβ-IN-5 can significantly improve scopolamine- and Aβ-induced cognitive impairment in mice .
Cat. No.: HY-P5340
CAS No.: 339091-39-3
Target:
Research Areas:
Cat. No.: HY-N12321
CAS No.: 54299-64-8
Target:
Cat. No.: HY-157441
Target:
Research Areas:
AChE/Aβ-IN-4 is a dual inhibitor of acetylcholinesterase (AChE) and β-amyloid (Aβ) aggregation, with the IC50 values of 1.72 ± 0.18 μM and 1.42 ± 0.3 μM, respectively. AChE/Aβ-IN-4 plays an impotant role in neurological disorders, such as Alzheimer’s disease .
Cat. No.: HY-175658
Target:
Research Areas:
AChE/BChE-IN-29 is an AChE/BChE inhibitor. AChE/BChE-IN-29 exhibits balanced dual cholinesterase inhibitory activity with IC50 values of 2.1 μM for Electrophorus electricus AChE (eeAChE) and 6.3 μM for equine serum butyrylcholinesterase (eqBChE). AChE/BChE-IN-29 effectively inhibits amyloid-β (Aβ42) aggregation and tau protein aggregation in E. coli cell models. AChE/BChE-IN-29 can be used for the study of Alzheimer’s disease (AD) .
Cat. No.: HY-144775
CAS No.: 2770832-90-9
Target:
Research Areas:
AChE-IN-10 (Compound 24r) is a potent inhibitor of AChE (IC50 = 2.4 nM). AChE-IN-10 potently inhibits AChE, reduces tau phosphorylation at S396 residue, provides neuroprotection by rescuing neuronal morphology and increasing cell viability. AChE-IN-10 is also found to reduce amyloid aggregation in the presence of AChE .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
